Our results showed that CD86 mRNA expression in tumor tissues was higher than that in normal bone tissues (Figure 7A), and elevated CD86 expression was beneficial to the prognosis of osteosarcoma (Supplementary Image S1). The gene discussed is CD86; the disease is neoplasm.